Treatment of Canine Atopic Dermatitis (CAD) Flashcards

1
Q

What does the owners need to understand once CAD has been diagnosed?

A
  • There is a need for further work to develop the correct protocol for their dog
  • There will be flares
  • We want to minimise the potential side-effects of therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does the disease pathogenesis influence the therapy used?

A

Complex, multifactorial pathogenesis
Genetic predisposition
- Skin barrier dysfunction
- Immune dysregulation – skin inflammation
Environmental factors
- Specific allergen sensitisation
- Enhanced microbial colonisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Treatment of CAD has which 4 aims?

A
  1. Improve the skin barrier
  2. Allergen avoidance and ASIT
  3. Control inflammation and pruritus
  4. Control flare factors (e.g. microbial overgrowth)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 3 aims of improving skin barrier function?

A
  1. Reduce transepidermal water loss
  2. Reduce exposure to environmental allergens and irritants
  3. Reduce microbial colonisation and cutaneous inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How can you improve the skin barrier?

A

Non irritating shampoos
Topical moisturisers and emollients
Supplementation with oral EFAs
Application of topical EFA - containing formulations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the aims of allergen avoidance and immunotherapy?

A
  • Only preventative therapy
  • Prevent/reduce worsening of clinical signs from further exposure to allergens
  • ‘Desensitisation’ to environmental allergens via induction of tolerant state in peripheral T cells (full mechanism unknown)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the most important allergens involved in CAD?

A

House dust
Storage mites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is allergen immunotherapy?

A
  • Administration of gradually increasing quantities of an allergen extract to an allergic subject to ameliorate the symptoms associated with subsequent exposure to the causative agent
  • Allergen intradermal testing (IDT) and/or IgE serology to identify specific hypersensitivities to environmental allergens
  • First confirm CAD diagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How long does allergen immunotherapy last?

A

Slow onset
4-6 months
Trial for a minimum of 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the aims of controlling inflammation and pruritis?

A
  • Long term reduction of inflammation
  • Avoid ‘peak and trough’ cycles of inflammation
  • Restoration of normal skin environment and prevention of microbial overgrowth
  • Avoid side effects through over dosage or overuse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name some anti-inflammatory and anti-pruritic therapies

A

Glucocorticoids - systemic and topical
Calcineurin inhibitors
Janus Kinase inhibitor
Oclacitinib [Apoquel®}
Antihistamines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List some adverse effects of systemic glucocorticoids

A

Polyphagia, PU/PD, panting, behaviour changes, iatrogenic hyperadrenocorticism, increased risk of UTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the use of topical glucocorticoids

A

Hydrocortisone aceponate 0.0584% (Cortavance®)
Topical diester glucocorticoid
Rapidly absorbed
Potent anti-inflammatory effects
Metabolised within the dermis
Minimal side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the main issue with topical steroid use?

A

Major safety risk is skin thinning with prolonged use (abdomen)
Intermittent application appears to prevent this and might delay flare recurrence of if

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the use of oral calcineurin inhibitors

A

Ciclosporin (Atopica®,Cyclavance®)
Inhibit T lymphocyte function via blocking calcineurin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

List the adverse effects of oral calcineurin inhibitors

A

GI signs
Gingival hyperplasia
Viral papillomas
Hirsuitism

17
Q

When is Janus kinase inhibitor (oclacitinib) contraindicated?

A

<12 months old or <3 kg BW
Breeding dogs or dogs with serious infections, underlying neoplasia or immune-suppression

18
Q

Describe the use of antihistamines in CAD

A

Best used as a preventative before the flare occurs and should be given on a continuous daily basis

19
Q

Each case of CAD should be considered on the basis of which 3 clinical factors?

A

Itch
Inflammation
Infection

20
Q

What is the drug of choice for moderate-severe CAD reactive therapy (induction of remission)?

A

Oral +/- topical glucocorticoids

21
Q

What is the drug of choice for mild CAD reactive therapy (induction of remission)?

A

Oclacitinib

22
Q

What is the drug of choice for moderate-severe CAD proactive therapy (prevention of reoccurrence)?

A

Oral +/- topical glucocorticoids

23
Q

What is the drug of choice for mild-moderate CAD proactive therapy (prevention of reoccurrence)?

A

Ciclosporin

24
Q

What is the drug of choice for mild CAD proactive therapy (prevention of reoccurrence)?

A

Oclacitinib

25
Q

Which factors of CAD may allow you to tailor treatment?

A
  • Chronicity
  • How long clinical signs been poorly controlled
  • Acute versus chronic
  • Distribution
  • Localised vs generalised disease
  • Focal ‘problem’ areas
  • Seasonality
  • Severity of disease
  • Risk of secondary infection